M&A advisors: "We've never seen such investor interest in this service before"
Danish and Nordic healthcare companies are sought after by specialized capital funds, with one particular segment having around 30 annual Nordic trades has garnered a lot of interest and sky-high valuations.
BY OLE ANDERSEN, KAPITALWATCH, TRANSLATED BY NIELSINE NIELSEN
Denmark and Sweden have started to resemble battle grounds for global and highly specialized healthcare investors competing for the most attractive Nordic biotech and life science companies in the steadily growing markets of the future.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
.jpg&w=384&q=75)
